Cargando…
M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects
[Image: see text] Tumor-associated macrophages (TAMs) usually display the tumor-promoting M2 phenotype rather than the tumoricidal M1 phenotype. Thus, M2-to-M1 repolarization of TAMs has emerged as a promising strategy for tumor immunotherapy nowadays. However, immune side effects remain a great cha...
Autores principales: | Xiao, Hong, Guo, Yu, Li, Bo, Li, Xiaoxia, Wang, Yong, Han, Shisong, Cheng, Du, Shuai, Xintao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379385/ https://www.ncbi.nlm.nih.gov/pubmed/32724855 http://dx.doi.org/10.1021/acscentsci.9b01235 |
Ejemplares similares
-
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng, Yuan, et al.
Publicado: (2018) -
Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012) -
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi, Ye, et al.
Publicado: (2018) -
The Codelivery of siRNA and QDs by pH-Responsive Micelle for Hepatoma Cancer Cells
por: Cao, Zhonglin, et al.
Publicado: (2019) -
PinX1-siRNA/mPEG-PEI-SPION combined with doxorubicin enhances the inhibition of glioma growth
por: LONG, LING, et al.
Publicado: (2014)